SAB Biotherapeutics Inc.

1.37
0.07 (5.38%)
At close: Apr 23, 2025, 3:52 PM
1.22
-11.23%
After-hours: Apr 23, 2025, 04:10 PM EDT

SAB Biotherapeutics Revenue

SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending December 31, 2024, SAB Biotherapeutics generated $114.7K in revenue.
Revenue (ttm)
$1.32M
Revenue Growth
-40.94%
Price / Sales Ratio
26.54
Revenue / Employee
$20.99K
Employees
63
Market Cap
12.73M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 1.32M -40.94%
Dec 31, 2023 2.24M -90.63%
Dec 31, 2022 23.9M -60.73%
Dec 31, 2021 60.88M +10.21%
Dec 31, 2020 55.24M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.